A detailed history of Velan Capital Investment Management LP transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Velan Capital Investment Management LP holds 574,000 shares of TARA stock, worth $1.31 Million. This represents 2.17% of its overall portfolio holdings.

Number of Shares
574,000
Previous 480,000 19.58%
Holding current value
$1.31 Million
Previous $998,000 5.21%
% of portfolio
2.17%
Previous 2.39%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.7 - $2.4 $159,800 - $225,600
94,000 Added 19.58%
574,000 $1.05 Million
Q2 2024

Aug 14, 2024

BUY
$1.96 - $4.14 $940,800 - $1.99 Million
480,000 New
480,000 $998,000

Others Institutions Holding TARA

About Protara Therapeutics, Inc.


  • Ticker TARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,267,400
  • Market Cap $25.8M
  • Description
  • Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...
More about TARA
Track This Portfolio

Track Velan Capital Investment Management LP Portfolio

Follow Velan Capital Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Velan Capital Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Velan Capital Investment Management LP with notifications on news.